Altwal F, Padovan-Neto FE, Ritger A, Steiner H, West AR (2021) Role of 5-HT1A receptor in vilazodone-mediated suppression of L-DOPA-induced dyskinesia and increased responsiveness to cortical input in striatal medium spiny neurons in an animal model of Parkinson’s disease. Molecules. https://doi.org/10.3390/molecules26195790

Article  PubMed  PubMed Central  Google Scholar 

Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of parkinson’s disease. Lancet Neurol 19:170–178. https://doi.org/10.1016/s1474-4422(19)30287-x

Article  PubMed  CAS  Google Scholar 

Cattaneo C, Jost WH (2023) Pain in Parkinson’s Disease: pathophysiology, classification and treatment. J Integr Neurosci 22:132. https://doi.org/10.31083/j.jin2205132

Article  PubMed  Google Scholar 

Chen X, Wang Z, Yang W, Fu Y (2024) Levodopa improves behavioral deficits of mice with Parkinson’s disease symptoms via curbing NLRP3 inflammasome activation and enhancing tyrosine hydroxylase levels in the striatum and substantia nigra. J Integr Neurosci 23:2. https://doi.org/10.31083/j.jin2301002

Article  PubMed  CAS  Google Scholar 

Clark EH, de la Vázquez Torre A, Hoshikawa T, Briston T (2021) Targeting mitophagy in Parkinson’s disease. J Biol Chem 296:100209. https://doi.org/10.1074/jbc.REV120.014294

Article  PubMed  CAS  Google Scholar 

de Lau LML, Breteler MMB (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535. https://doi.org/10.1016/s1474-4422(06)70471-9

Article  PubMed  Google Scholar 

Han H, Tan J, Wang R et al (2020) PINK1 phosphorylates Drp1(S616) to regulate mitophagy-independent mitochondrial dynamics. EMBO Rep 21:e48686. https://doi.org/10.15252/embr.201948686

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jankovic J, Tan EK (2020) Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91:795–808. https://doi.org/10.1136/jnnp-2019-322338

Article  PubMed  Google Scholar 

Ji LL, Huang TT, Mao LL, Xu YF, Chen WY, Wang WW, Wang LH (2023) The gut microbiota metabolite butyrate mitigates MPTP/MPP(+) -induced parkinson’s disease by inhibiting the JAK2/STAT3 signaling pathway. Kaohsiung J Med Sci 39:1002–1010. https://doi.org/10.1002/kjm2.12745

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li H, Li Y, Zhang X et al (2020) The combination of Aquilaria sinensis (Lour.) Gilg and Aucklandia costus Falc. volatile oils exerts antidepressant effects in a CUMS-induced rat model by regulating the HPA axis and levels of neurotransmitters. Front Pharmacol 11:614413. https://doi.org/10.3389/fphar.2020.614413

Article  PubMed  CAS  Google Scholar 

Li Y, Xia Y, Yin S et al (2021) Targeting microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson’s disease. Front Immunol 12:719807. https://doi.org/10.3389/fimmu.2021.719807

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu L, Zhou T, Li T, Liang Z, Luo X (2022) LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson’s disease by regulating the miR-223-3p/NRP1 axis. Behav Brain Res 431:113923. https://doi.org/10.1016/j.bbr.2022.113923

Article  PubMed  CAS  Google Scholar 

Liu T, Wang P, Yin H, Wang X, Lv J, Yuan J, Zhu J, Wang Y (2023) Rapamycin reverses ferroptosis by increasing autophagy in MPTP/MPP(+)-induced models of parkinson’s disease. Neural Regen Res 18:2514–2519. https://doi.org/10.4103/1673-5374.371381

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lu J, Liu X, Tian Y et al (2019) Moxibustion exerts a neuroprotective effect through antiferroptosis in Parkinson’s disease. Evid Based Complement Alternat Med 2019:2735492. https://doi.org/10.1155/2019/2735492

Article  PubMed  PubMed Central  Google Scholar 

Mancuso R, Agostini S, Hernis A, Zanzottera M, Bianchi A, Clerici M (2019) Circulatory miR-223-3p discriminates between Parkinson’s and Alzheimer’s patients. Sci Rep 9:9393. https://doi.org/10.1038/s41598-019-45687-x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Min N, Ma J, Shi L, Wang L, Liu C, Zhang Y, Xue Q (2024) MiR-223 promotes cartilage differentiation of bone marrow-derived mesenchymal stem cells and protects against osteoarthritis by suppressing NLRP-3 expression. Arch Med Sci 20:2002–2008. https://doi.org/10.5114/aoms.2020.100640

Article  PubMed  CAS  Google Scholar 

Panicker N, Kam TI, Wang H et al (2022) Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in parkinson’s disease. Neuron 110:2422–2437e2429. https://doi.org/10.1016/j.neuron.2022.05.009

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rani L, Mondal AC (2024) Vanillin mitigates the MPTP-Induced α-Synucleinopathy in a mouse model of Parkinson’s Disease: insights into the involvement of Wnt/β-Catenin signaling. J Integr Neurosci 23:175. https://doi.org/10.31083/j.jin2309175

Article  PubMed  Google Scholar 

Sokolove J, Lepus CM (2013) Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 5:77–94. https://doi.org/10.1177/1759720x12467868

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sun Z, Gao Z, Wu J, Zheng X, Jing S, Wang W (2022) MSC-Derived extracellular vesicles activate mitophagy to alleviate renal ischemia/reperfusion injury via the miR-223-3p/NLRP3 axis. Stem Cells Int 2022:6852661. https://doi.org/10.1155/2022/6852661

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of parkinson’s disease. Lancet Neurol 20:385–397. https://doi.org/10.1016/s1474-4422(21)00030-2

Article  PubMed  PubMed Central  CAS  Google Scholar 

Van Den Eeden SK (2003) Incidence of Parkinson’s Disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157:1015–1022. https://doi.org/10.1093/aje/kwg068

Article  PubMed  Google Scholar 

Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T (2021) Progress towards therapies for disease modification in parkinson’s disease. Lancet Neurol 20:559–572. https://doi.org/10.1016/s1474-4422(21)00061-2

Article  PubMed  CAS  Google Scholar 

Wang WW, Han R, He HJ, Li J, Chen SY, Gu Y, Xie C (2021) Administration of Quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned parkinson’s disease models. Aging 13:11738–11751. https://doi.org/10.18632/aging.202868

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang L, Wu X, Yang G, Hu N, Zhao Z, Zhao L, Li S (2022) Cannabidiol alleviates the damage to dopaminergic neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced parkinson’s disease mice via regulating neuronal apoptosis and neuroinflammation. Neuroscience 498:64–72. https://doi.org/10.1016/j.neuroscience.2022.06.036

Article  PubMed  CAS  Google Scholar 

Wang L, Tian S, Ruan S et al (2024) Neuroprotective effects of cordycepin on MPTP-induced Parkinson’s disease mice via suppressing PI3K/AKT/mTOR and MAPK-mediated neuroinflammation. Free Radic Biol Med 216:60–77. https://doi.org/10.1016/j.freeradbiomed.2024.02.023

Article  PubMed  CAS  Google Scholar 

Wu L, Xu Q, Zhou M et al (2022) Plasma miR-153 and miR-223 levels as potential biomarkers in Parkinson’s disease. Front Neurosci 16:865139. https://doi.org/10.3389/fnins.2022.865139

Article  PubMed  PubMed Central